Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHRQ posts review on secondary lymphedema

This article was originally published in The Gray Sheet

Executive Summary

Agency for Healthcare Research and Quality's finalized technology assessment on the diagnosis and treatment of secondary lymphedema says that more research is needed to gather evidence on the optimal testing protocol, optimal frequency and duration of treatment, the most efficacious treatment combinations, the length of time for which persons should be tested or treated for lymphedema and whether certain tests or treatments may benefit some types of patients more than others. The report, dated May 28, updates a draft report released last November (1"The Gray Sheet" Nov. 18, 2009). It also adds evidence from non-English-language studies that were excluded from the earlier technology assessment and that were requested by a Medicare Evidence Development & Coverage Advisory Committee that met in Baltimore last November (2"The Gray Sheet" Nov. 23, 2009). Because much of the available evidence on secondary lymphedema comes from studies of breast cancer patients, the report says, diagnostic tests should also be evaluated in non-breast cancer populations before they are widely used for the condition
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT029125

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel